REACH Trademark

Trademark Overview


On Tuesday, April 12, 2022, a trademark application was filed for REACH with the United States Patent and Trademark Office. The USPTO has given the REACH trademark a serial number of 97359714. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 1, 2024. This trademark is owned by Fulcrum Therapeutics, Inc.. The REACH trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines
reach

General Information


Serial Number97359714
Word MarkREACH
Filing DateTuesday, April 12, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, May 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Description of MarkThe mark consists of the word "REACH" with an asymmetrical wave shaped line above the letters "A", "C" and "H", and above the line between the letters a and "C" is an opaque circle.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Goods and ServicesClinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 15, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFulcrum Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameFulcrum Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, April 15, 2022NEW APPLICATION ENTERED
Tuesday, April 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 20, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, November 27, 2022ASSIGNED TO EXAMINER
Monday, December 12, 2022NON-FINAL ACTION WRITTEN
Monday, December 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2022NON-FINAL ACTION E-MAILED
Monday, March 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2023SOU EXTENSION 1 FILED
Monday, December 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 18, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 19, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, December 19, 2023PETITION TO REVIVE-GRANTED
Tuesday, December 19, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, December 19, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, December 19, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, February 7, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 9, 2024SOU EXTENSION 1 GRANTED
Saturday, February 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 1, 2024SOU EXTENSION 2 FILED
Wednesday, May 1, 2024SOU EXTENSION 2 GRANTED
Thursday, May 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED